Yahoo Web Search

Search results

    • Neurocrine Biosciences Announces CEO Succession Plan

      The Yuma Sun· 17 hours ago

      Neurocrine Biosciences, Inc. (Nasdaq: NBIX), today announced that Kevin Gorman, Ph.D., will retire as Chief Executive Officer of Neurocrine on October 11, 2024. Kyle Gano, Ph.D., currently Neurocrine's ...